Highest Binding Capacity on the Market. SoluLinK, San Diego, California. (PRNewsFoto/SoluLinK, Inc.) SAN DIEGO, May 28 — SoluLinK, Inc., a leader in next-generation conjugation products and kits, is proud to announce the introduction of a new product, NanoLink(TM) Streptavidin Magnetic Microspheres. These sub-micron particles possess the highest biotin-binding capacity of any commercially available polymer-encapsulated streptavidin […]
Company Adds New Kits to Differentiate Mesenchymal Stem Cells CARLSBAD, Calif.–Invitrogen Corporation (NASDAQ:IVGN – News), a provider of essential life science technologies for research, production and diagnostics, announced the launch of a serum free media (SFM) designed specifically to culture mesenchymal stem cells (MSCs), or stem cells derived from bone marrow. STEMPRO® MSC SFM is […]
MADISON, Wisc., May 22, 2008 – Promega Corporation, a leading provider of trypsin protease to the life sciences industry, announces the launch of ProteasMAX(tm) Surfactant . ProteasMAX has been designed to enhance the enzymatic performance of trypsin and other proteases in preparation for analysis by mass spectrometry or liquid chromatography. The surfactant enables scientists to […]
CARLSBAD, Calif.–Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the launch of the SequalPrep™ System; a complete sample enrichment and normalization solution for next generation sequencing technologies that consists of the SequalPrep™ Long PCR Kit and the SequalPrep™ Normalization Plate (96) Kit. One of the most […]
ST. LOUIS, May 14 — Sigma-Aldrich (Nasdaq: SIAL – News) announced today that Chief Administrative Officer and Chief Financial Officer Michael R. Hogan will retire at a date to be determined this summer. Hogan, who turned 55 in April, had notified the Company early this year of his desire to retire as soon as his […]
Joint development and collaboration enables enhanced production of every human protein, spurring advances in drug development Venlo, The Netherlands — May 14, 2008 – QIAGEN (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) and GENEART (Frankfurt, Entry Standard, G6A) announced their collaboration to develop, produce and commercialize a new product line for the enhanced production of all […]
CARLSBAD, Calif. & MADISON, Wis.–Invitrogen Corporation (NASDAQ:IVGN – News), a provider of essential life science technologies for research, production and diagnostics, and the Wisconsin Alumni Research Foundation (WARF), the private, non-profit patenting and licensing organization for the University of Wisconsin-Madison, announced today that they have signed a license for human embryonic stem cell (hESC) patents […]
ST. LOUIS, May 7 — Sigma-Aldrich(TM) (Nasdaq: SIAL – News) and the second phase of The RNAi Consortium (TRC2) have commenced functional validation of the Consortium’s collection of approximately 160,000 previously-cloned lentiviral-based shRNA vector constructs. Currently, more than 5,000 clones have been tested in the functional validation process. Validated clones covering more than 700 genes […]
CARLSBAD, Calif. & BELTSVILLE, Md.–In research demonstrating that RNA previously thought to have no biological relevance may be of use for therapeutic and diagnostic targets, Invitrogen Corporation (NASDAQ:IVGN – News), a provider of essential life science technologies for research, production and diagnostics, and BioServe, the leading provider of clinically annotated tissue samples and provider of […]
Portfolio to be made available through SDI’s SEQer(TM) Antibody Product Catalog NEWARK, Del.–Strategic Diagnostics Inc. (Nasdaq: SDIX – News) – a leading provider of biotechnology-based detection solutions for a broad range of food, water, agricultural, industrial, environmental and life science applications, announced that it will be providing Jason Lieb’s Laboratory at University of North Carolina, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
